3번4 56
3번4 56
Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic: Department of Physiology1;
GENERI BIOTECH Ltd., Hradec Králové, Czech Republic2
Summary: Liver regeneration in mammals is a unique phenomenon attracting scientific interest for decades. It is a valu-
able model for basic biology research of cell cycle control as well as for clinically oriented studies of wide and heteroge-
neous group of liver diseases. This article provides a concise review of current knowledge about the liver regeneration,
focusing mainly on rat partial hepatectomy model. The three main recognized phases of the regenerative response are de-
scribed. The article also summarizes history of molecular biology approaches to the topic and finally comments on
obstacles in interpreting the data obtained from large scale microarray-based gene expression analyses.
Key words: Liver Regeneration; Hepatectomy; Gene Expression; Microarray, Hepatocytes; Rat
92
months the recovery of original mass is complete. Trans-
plant clinician Manzarbeitia (2002) in clinical setting of
living donor liver transplantations witnesses almost com-
plete restoration of both the donors’ and recipients’ livers
in 6–8 weeks, with most of the recovery occurring in the
first two weeks. Older report by Jansen (1990) found out
maximal 75±2 % size recovery after a post partial hepatec-
tomy follow-up period of 50 days. Taken together it is not
simple to determine the time needed for ultimate recovery
in humans and the comprehensive discussion of this issue
is above the frame of this article.
93
nalling pathways action in short time after an insult. It is During the proliferative phase almost all of the hepato-
concluded that the triggering factors must be in place faster cytes undergo mitosis. This percentage is approximately
than de novo proteosynthesis could occur and that they are 95 % in young rats and decreases to about 70 % in old ani-
substances already present in the body. One of the sug- mals (3, 46). The mechanism of replicative senescence of
gested early initiators is lipopolysaccharide (LPS), pro- the hepatocytes is not clarified so far. In humans there are
duced by the gut flora and released from the intestines as less observations of such kind available, but in liver trans-
a consequence of deteriorated intestinal barrier due to sur- plantation grafts from younger donors generally carry bet-
gical stress. LPS reaches liver with the portal blood and can ter outcome (67).
readily influence its cells. The LPS activates the non-pa- Not all the hepatocytes that passed the S phase finally
renchymal cells (including Kupffer cells and stellate cells) replicate. The proportion of binucleate cells within the liver
and increases their production of tumour necrosis factor increases, and some hepatocytes become polyploid but un-
alpha (TNFα) and interleukin 6 (IL-6) (56). Another sub- divided. The first mitotic wave concerning the vast majori-
stances acting as rapidly as LPS are activated complement ty of parenchymal cells is followed by a second one, about
compound C3a and C5a, showing that the response is not 48 hours after PH, involving smaller percentage of hepato-
isolated to the liver itself, but that the circulating factors cytes. In total there is about 1.6 cycles of replication in all
take part as well (35, 53). cells to fully restore the liver (56).
Cytokine signals including TNFα and IL-6 cause tran-
scription factors NFκB, STAT3, AP-1 and CEBPβ to bind Termination phase
DNA rapidly by means of their posttranslational modifica-
tions (6, 12). Subsequently, in 20 to 30 minutes after the Cessation of the regenerative response is the least eluci-
PH, derepressed transcription factors increase expression dated phase of the process. It is still not clear whether it
of so called immediate early genes. These include the pro- is onset of inhibitory agents or withdrawal of stimulatory
tooncogenes c-fos, c-jun, c-myc and c-met, the latter being substances that finally stops regeneration. The interplay
the HGF receptor (52). among the liver cell subpopulations and probable parti-
Cytokine mediated pathway is responsible for G0/G1 cipation of the recovered extracellular matrix complicate
transition, after which the action of growth factors is ine- revealing the mechanisms of observed precise liver size re-
vitable. Complete hepatic mitogens recognised in vivo and gulation. Nonparenchymal cells may mediate the inhibition
also in primary hepatocyte cultures are HGF, TGFα, and of regrowth during structural reorganisation of the liver
EGF. These allow cells to overcome the G1 restriction which comes after the volume regain is finished. Reap-
point and continue towards mitosis (32). pearing extracellular matrix may play an important role by
Extrahepatic body organs also have a role to play in re- renewed binding of pro-HGF (35).
action to liver injury. Cooperative priming signals come Mechanisms that link the replicative activity of hepato-
from the pancreas (insulin), duodenum or salivary glands cytes in the regenerating liver with body functional demands,
(EGF; epidermal growth factor), thyroid gland (T3, triiod- have been sought and mammalian target of rapamycin
thyronine) and adrenal glands (norepinephrine). These co- (mTOR) and its downstream effectors belong to proposed
mitogens help initiate the recovery of the liver (7, 8, 30, 56). candidates (11).
Factors with known inhibitory effects on hepatocyte
Proliferative phase proliferation in cultures such as TGF-β1 (in vivo normally
synthesized by Ito cells) have been subject of research.
Proliferative phase is characterised by mitotic waves of Some observations suggest that disappearance of (detect-
hepatic cells. The well obvious marker of the cell cycle pro- able) tissue TGF-β1 from periportal to pericentral region
gression is the rate of DNA synthesis observed to appear in of lobule enables progression of hepatocyte mitotic wave
a coordinated fashion in individual liver cell subpopula- in the same direction at the onset of regeneration. TGF-β1
tions. Hepatocytes reach the S phase first, with the DNA released in the plasma shortly after PH is probably inac-
synthesis beginning to rise 12 hours after the PH and peaking tivated by binding to α2 macroglobulin. Hepatocytes them-
at about 24 hours after the operation. The S phase in the selves are transiently resistant to mito-inhibitory effects
nonparenchymal cells occurs later; at 48 hours for Kupf- of TGF-β1 during the proliferative phase. After this re-
fer and biliary cells and around 96 hours for endothelial fractory period, TGF-β1 could play a role in ending the re-
cells (12, 56). After an insult causing necrosis or apopto- generation, however in transgenic mice overexpressing
sis of hepatocytes, the course of the cell priming is similar TGF-β1 regeneration is slowed down but it finally comple-
as after the PH, but the replicative waves are less coordi- tes (5, 37). Related TGFβ family members, such as activin,
nated. act similarly.
Functional heterogeneity of hepatocytes applies also to Several negative feedback loop interactions related to
the onset of DNA synthesis within the liver acini, starting priming phase stimuli were recognised. To name some of
around the portal vein (zone I) and gradually proceeding these: plasminogen activator inhibitor (PAI) induced by
towards the central vein (zone III). IL-6, blocks the HGF action by preventing the cleavage of
94
pro-HGF into an active HGF. Suppressor of cytokine sig- sion patterns, which is based on assumption that common
nalling-3 (SOCS3) upregulated downstream to IL-6, causes activation or suppression indicates functional relationships
downregulation of phosphorylated signal transducer and among transcripts. Much database searching necessarily
activator of transcription 3 (STAT3) ultimately terminating follows when interpreting the findings (15, 39, 59, 64).
the original IL-6 signal (56). Extensive use of public data repositories and bioinformatic
Apoptosis, as a possible mechanism correcting the re- platforms fosters their rapid development.
sultant size of the liver was studied in normal and IL-6 -/- Real time PCR gene expression analyses usually com-
mice, by Sakamoto et al (1999). This work suggested greater plement high throughput methods. Either as a confirmative
role of apoptosis in normal than in IL-6 deficient liver in approach for selected genes or as a preliminary method for
eliminating the superfluous hepatocytes generated by rege- more precise focusing of laborious and expensive advanced
neration. techniques. Moreover the real time PCR provides wider
linear dynamic range of transcript quantitation and thus re-
Molecular biology methods to study fines the results. Work by Cimica et al. (2007), who used se-
mechanisms of the liver regeneration rial analysis of gene expression (SAGE) for one post partial
hepatectomy interval based on previous real time PCR and
Given the long history of research interest in the liver immunostaining results, is a recent example of such combi-
regeneration, it is not surprising, that it has been studied by nation of methods.
molecular biology methods as well. Early works, in the Interesting novel approach was used by Juskeviciute et
1980’s, assessed the presence and relative abundance of the al. (2008), who were able to identify previously unknown
specific mRNAs by autoradiography measurements fol- transcription factors participating in liver regeneration,
lowing membrane-based hybridisation techniques like Nor- thanks to bioinformatic analysis of shared transcription fac-
thern blot and Dot blot (21, 29, 58). These approaches tor binding sites in the clustered microarray data.
were eventually complemented by histochemistry and cyto-
genetic methods (36). These works mostly dealt with seve- Interpreting recent microarray data
ral genes of interest focusing on narrowly specified aspects
of hepatocyte growth. Experiments by Taub and co-workers Majority of so far published papers is focused on early
outstand by the number of genes analysed and the time in- changes after the liver insult, based on the notion, that the
tervals studied (18). reactivation from quiescence and subsequent entry into the
Experiments using the genetically engineered mice S phase of the cell cycle is the most exceptional feature of
strains gained wider use in 1990’s. The ability to perma- liver regeneration model. Propagation of the proliferative
nently or transiently overexpress or suppress (knock out) response seems to follow the same principles as seen in
a gene of choice has enabled much progress in studying the other extrahepatic cells or tissues, making later phases of
involvement of individual factors or whole transcription regeneration less scientifically attractive. This general fact
pathways in the process (2, 13). applies to microarray-based analyses as well.
Advent of microarray platforms, introduced in 1995, al- As seen in Tab. 1, summarising several features of seven
lowed for wider scope of gene expression analyses. Simul- recently published studies using microarrays, the sample ac-
taneous gene expression analyses of thousands of genes quisition is usually denser in shorter intervals and becomes
raised a new challenge. It is now demanding to sort out ge- notably looser after 24 hours after the resection. Thus it
nes truly related to the observed functional or morpholo- would seem logical; that the molecular mechanisms under-
gical changes among many detected by high throughput lying the first 12 or 24 hours of liver regeneration should be
microarray experiments. Usually time course of expression well described and understood in good agreement among
alterations after the intervention is used as a criterion for the researchers. Unfortunately the situation is more com-
creating clusters, subgroups of genes with similar expres- plicated. Anyone trying to interpret the findings of large
Tab. 1: Recently published microarray-based works on liver regeneration and their sampling intervals.
First Model
PY Post partial hepatectomy sampling intervals
author organism
Mortensen 2008 pig 1 m 30 m 90 m 3h 4h 6h
Fukuhara 2003 rat 6h 12 h 18 h 24 h 48 h 72 h 168 h
Togo 2004 mouse 60 m 3h 6h 12 h 24 h
Xu 2005 rat 2h 4h 8 h 12 h 16 h 24 h 36 h 48 h 72 h 96 h 144 h
Shao 2007 rat 30 m 60 m 2h 4 h 6 h 8 h 12 h 24 h 36 h 54 h 66 h 72 h 120 h144 h168 h
Yokoya 2004 rat 60 m 6h 24 h 48 h 168 h
Xu 2007 rat 30 m 60 m 2h 4 h 6 h 8 h 12 h 16 h 18 h 24 h 30 h 36 h 42 h 48 h 54 h 60 h 66 h 72 h 96 h 120 h144 h168 h
PY = year of publication; m = minute(s); h = hours(s)
95
Tab. 2: Differentially expressed genes common to at least two of the three compared microarray-based studies recently
published on liver regeneration after partial hepatectomy in rodents.
Published in article
Gene name and its alternatives (including symbols)* – Ref. No.
64 47 66
Cytochrome P450, family 7, subfamily a, polypeptide 1, Cyp 7a1, P-450 cholesterol X X
7-alpha-hydroxylase, Cholesterol 7-alpha-monooxygenase
Connective tissue growth factor precursor (Connective tissue growth-related protein). Ctgf X X
Dual specificity protein phosphatase 1 (EC 3.1.3.48) (EC 3.1.3.16) (MAP kinase phosphatase 1) X X
(MKP-1) (Protein-tyrosine phosphatase CL100) (Protein-tyrosine phosphatase non-receptor
type 16).
Early growth response factor 1 (Egr1) (KROX-24 PROTEIN) (ZIF268) (NERVE GROWTH X X
FACTOR-INDUCED PROTEIN A) (NGFI-A)
Plasminogen activator inhibitor 1 precursor (PAI-1) (Endothelial plasminogen activator inhibitor) X X X
(PAI) Serine protease inhibitor 1(Serpin 1) (Serpine1)
Cytochrome P450 15-beta (Cyp2c12) X X
Alpha-2-macroglobulin precursor (Alpha-2-M). A2m X X X
Bile acid CoA:amino acid N-acyltransferase (EC 2.3.1.65) (BAT) (BACAT) (Glycine X X
N-choloyltransferase) (Kan-1) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2). (Baat)
(Hepatic) Flavin-containing monooxygenase 1 (Fmo1) X X
*found in Ensembl Genome Browser and Entrez Gene databases (23, 33)
scale gene expression studies, as these listed, soon encoun- should unravel the temporal pattern of their involvement.
ters several principal difficulties. Are we able to answer these questions then? Well, it is not
Firstly, the overlap between the results of microarray- rare that authors group their explored differentially expres-
based studies is commonly much smaller than would be sed genes into categories based on functional relationships
expected. As noted by van Bakel and Holstege (2008), com- (e.g. 57), but the problem again occurs when trying to clas-
paring independently obtained lists of differentially expres- sify genes from more studies together. Still, it is the uncer-
sed genes from several experiments on the same topic may tainty in describing the genes, what complicates this task.
end up in very limited number of shared matches. In the Fortunately, sophisticated and moreover user-friendly tools
model example shown in their work, three gene lists con- were developed to ease such an effort. What we strive to get
taining 115, 160 and 250 genes respectively, only 15 genes is the functional classification of genes and there are bioin-
were common to all the lists. We made a similar experience formatic instruments available to do that. One of the pos-
comparing three published gene lists from references 63, 47 sible ones is DAVID database accessible free of charge via
and 66 and yielding mere nine genes common to at least the internet (22; this work also lists some alternative tools
two of the three works (see Tab. 2). This is caused most for functional annotation and principles they utilize in its
probably by varied microarray platforms and methodology Supplementary Data 1).
of working with the data, e.g. different cut off values for fold With help of DAVID database we searched through gene
change in gene expression level. lists derived from the seven papers listed in Tab. 1. Doing the
Interpreting effort is moreover complicated by nonuni- same comparison among the gene lists „manually“ without
form way of presenting results, regarding the gene names, such an aid is obviously laborious and thus discouraging.
symbols or database annotations. Not having the raw data, To avoid that, we wanted to begin the work with well
reader of the papers is dependent on some of the compre- characterised background. This we derived from Gene
hensive databases such as Entrez Gene (33), Ensembl Ge- Ontology database (57). We chose the biological process
nome Browser (23) or Rat Genome Database (RGD) (60) GO:0006953~acute-phase response, surely involved in ear-
in finding the missing descriptors to decide whether the ly phases of liver regeneration after surgical resection. For
gene results from different studies do or do not overlap. The Rattus norvegicus species there were 23 gene products an-
authors list their gene results with various level of exact- notated under this term in GO database release 2009-09-24.
ness, not always using unambiguous names or codes like We consequently used these genes as a user defined Gene
Entrez Gene ID, Ensembl Gene ID or RGD Gene ID. List for upload into the DAVID database. There, using the
The most desired information from large scale studies is ID conversion tool, we were able to obtain unambiguous
not about several individual genes confirmed among thou- descriptors for all the 23 genes. We decided for conversion
sands under investigation, but about functional classes or into following four categories: RGD ID, GENE SYMBOL,
even better cellular pathways involved in the particular ENTREZ GENE ID and UNIGENE. Results of the con-
steps of liver regeneration. Time course experiments also version are summarized in the Tab. 3.
96
Tab. 3: Genes involved in acute phase response and their coverage in the seven compared microarray-based studies.
Ref No. 64 47 66 39 59 15 65
Gene Name RGD ID GENE ENTREZ UNIGENE
SYMBOL GENE ID
BILE ACID-COENZYME A: AMINO ACID 2190 BAAT 29725 RN.11129 X X X
N-ACYLTRANSFERASE
LIPOPOLYSACCHARIDE BINDING 61865 LBP 29469 RN.48863
PROTEIN
TRANSIENT RECEPTOR POTENTIAL 628841 TRPV1 83810 RN.3073
CATION CHANNEL, SUBFAMILY V,
MEMBER 1
TRANSFERRIN 3845 TF 24825 RN.91296
ENDOTHELIN RECEPTOR TYPE B 2536 EDNRB 50672 RN.11412
PROSTAGLANDIN E RECEPTOR 3 3435 PTGER3 24929 RN.10361 X
(SUBTYPE EP3)
INTERLEUKIN 1 BETA 2891 IL1B 24494 RN.9869
SIGNAL TRANSDUCER AND ACTIVATOR 3772 STAT3 25125 RN.10247 X
OF TRANSCRIPTION 3
ALPHA-2-MACROGLOBULIN 2004 A2M 24153 RN.780 X X X X
TUBEROUS SCLEROSIS 2 3908 TSC2 24855 RN.5875
PHOSPHOLIPASE A2, GROUP IVA 67366 PLA2G4A 24653 RN.10162
(CYTOSOLIC, CALCIUM-DEPENDENT)
TRANSFERRIN RECEPTOR 70488 TFRC 64678 RN.98672
SIMILAR TO SINGLE IG IL-1 RECEPTOR 1306732 SIGIRR 309106 RN.16525
RELATED PROTEIN
INSULIN 2 2916 INS2 24506 RN.989
CCAAT/ENHANCER BINDING PROTEIN 2326 CEBPA 24252 RN.22163
(C/EBP), ALPHA
EPH RECEPTOR A3 68389 EPHA3 29210 RN.10713
ARGININOSUCCINATE SYNTHETASE 2163 ASS 25698 RN.5078
CHEMOKINE (C-C) RECEPTOR 5 620596 CCR5 117029 RN.10736
INTERLEUKIN 1 RECEPTOR 621159 IL1RN 60582 RN.85806 X
ANTAGONIST
MACROPHAGE INFLAMMATORY 708446 CCR1 57301 RN.34673
PROTEIN-1 ALPHA RECEPTOR GENE
ALPHA-2-HS-GLYCOPROTEIN 2075 AHSG 25373 RN.32083
SIGNAL TRANSDUCER AND ACTIVATOR 3774 STAT5B 25126 RN.54486
OF TRANSCRIPTION 5B
CHEMOKINE (C-C MOTIF) LIGAND 5 69069 CCL5 81780 RN.8019
Thanks to this prerequisite, searching for the genes in- any of the Gene Ontology functional categories, allowing
volved in the acute phase response among all the seven large anyone interested to focus on the field of their study.
scale studies became significantly more efficient. Resultant
findings are also in the Tab. 3. Although there are again only Conclusion
scarce matches to the gene products we were looking for,
confirming small overlap between independent papers, we This article deals with liver regeneration, the unique abi-
want to emphasize the benefit of such interpreting proce- lity of the liver to recover from serious damages. The artic-
dure. It lies mainly in removing uncertainty from the gene le describes significance of this interdisciplinary study topic
specifications and thus allowing comparison of the results and summarizes current knowledge in the field. Particular
originally presented using different ways, e.g. only gene names attention is paid to molecular biology methods utilized in li-
or its symbols vs. giving the database descriptors which un- ver regeneration studies. Finally, authors provide a discus-
fortunately may turn obsolete from the time of publication. sion of possible obstacles in interpreting the recent findings
The latter being frequent impediment given the perpetually from microarray-based studies and propose their way of cir-
ongoing refinements and updates to the internet-based geno- cumventing them as a solution for others experiencing si-
mic databases. Finally, the similar approach may be used for milar difficulties.
97
Acknowledgement 22. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of
large gene lists using DAVID Bioinformatics Resources. Nature Protocols
The work described in this article is supported by Mi- 2009;4(1):44–57.
nistry of Education grant MSM 0021620820, Charles 23. Hubbard TJP, Aken BL, Ayling S, et al. Ensembl 2009. Nucleic Acids Research
[online] 2009;37:D690–D697.
University Grant Agency grant No. 9945/2009(94509) and 24. Humar A, Kosari K, Sielaff TD, et al. Liver regeneration after adult living donor
Internal grant of the Charles University in Prague, Faculty and deceased donor split-liver transplants. Liver Transpl 2004;10:374–8.
of Medicine in Hradec Králové with support from ROCHE, 25. Ikeda T, Sawada N, Fujinaga K, Minase T, Mori M. c-H-ras gene is expressed at
the G1 phase in primary cultures of hepatocytes. Exp. Cell Res. 1989;185:292–6.
No. 84024. 26. Jansen PL, Chamuleau RA, van Leeuwen DJ, Schipper HG, Busemann-Sokole E,
van der Heyde MN. Liver regeneration and restoration of liver function after par-
tial hepatectomy in patients with liver tumors. Scand J Gastroenterol 1990;25(2):
List of abbreviations 112–8.
27. Juskeviciute E, Vadigepalli R, Hoek JB. Temporal and functional profile of the
AP-1, activator protein 1 (= c-jun); CEBP, CCAAT/en- transcriptional regulatory network in the early regenerative response to partial he-
patectomy in the rat. BMC Genomics 2008;9:527.
hancer binding protein; EGF, epidermal growth factor; 28. Krejsek J, Kopecký O. Klinická imunologie. 1st ed. Hradec Králové: NUCLEUS
HGF, hepatocyte growth factor; NFκB, nuclear factor of HK, 2004:968.
29. Kruijer W, Skelly H, Botteri F, et al. Proto-oncogene expression in regenerating
kappa light polypeptide gene enhancer in B-cells; PAI, liver is simulated in cultures of primary adult rat hepatocytes. J Biol Chem 1986;
plasminogen activator inhibitor; SOCS3, suppressor of cy- 261:7929–33.
30. Křiváková P. Hepatocyty jako modelový systém pro studium poruch energetické-
tokine signalling-3; STAT3, signal transducer and activator ho metabolismu (Dissertation). [s.l.]: Univerzita Karlova v Praze, Lékařská fa-
of transcription 3; TGF, transforming growth factor kulta v Hradci Králové, 2006. 135pp.
31. Liu ML, Mars WM, Zarnegar R, Michalopoulos GK. Collagenase pretreatment
and the mitogenic effects of hepatocyte growth factor and transforming growth
References factor-alpha in adult rat liver. Hepatology 1994;19:1521–7.
32. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. Growth
1. Beavers KL, Sandler RS, Shresta R. Donor morbidity assosciated with right lo- factor dependence of progression through G1 and S phases of adult rat hepato-
bectomy for living donor liver transplantation to adult recipients: a systematic re- cytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem
view. Liver Transplantation 2002;8:110–17. 1996;271(19):11484–92.
2. Braun KM, Sandgren EP. Liver disease and compensatory growth: unexpected 33. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered informa-
lessons from genetically altered mice. Int J Dev Biol 1998;42:935–42. tion at NCBI. Nucleic Acids Research [online] 2005;33:D54–D58.
3. Bucher NL. Regeneration of mammalian liver. Int Rev Cytol 1963;15:245–300. 34. Manzarbeitia C, ed. Practical Manual of Abdominal Organ Transplantation. New
4. Cimica V, Batusic D, Haralanova-Ilieva B, et al. Serial analysis of gene expression York: Kluwer Academic Publishers, 2002.
(SAGE) in rat liver regeneration. Biochem Biophys Res Commun 2007;360:545–52. 35. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA. Lambris JD. A novel role
5. Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. The mystery of liver of complement: mice deficient in the fifth component of complement (C5) exhi-
regeneration. British Journal of Surgery 2002;89:1089–95. bit impaired liver regeneration. J Immunol 2001;166:2479–86.
6. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective 36. Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle
hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379–83. RL. Liver regeneration studies with rat hepatocytes in primary culture. Cancer
7. Červinková Z, Šimek J, Trojovská V. Effect of triiodothyronine or etiroxate on Res 1982;42:4673–82.
DNA synthesis in intact and regenerating liver. Physiol bohemoslov 1984; 37. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60–6.
33(6):501–6. 38. Michalopoulos GK. Liver Regeneration. Journal of Cellular Physiology 2007;
8. Červinková Z, Šimek J. Effect of propylthiouracil on liver regeneration in rats af- 213:286–300.
ter partial hepatectomy. Physiol Res 1992;41:141–6. 39. Mortensen KE, Conley LN, Hedegaard J, et al.: Regenerative response in the pig
9. Erhard J, Lange R, Giebler R, Rauen U, de Groot H, Eigler FW. Arterialization liver remnant varies with the degree of resection and rise in portal pressure. Am
of the portal vein in orthotopic and auxiliary liver transplantation. A report of J Physiol Gastrointest Liver Physiol 2008;294:G819–30.
three cases. Transplantation 1995;60:877–90. 40. Ogata A, Miyazaki M, Ohtawa S, Ohtsuka M, Nakajima N. Short-term effects of
10. Etienne PL, Baffet G, Desvergne B, Boisnard-Rissel M, Glaise D, Guguen- portal vein arterialization on hepatic protein synthesis and endotoxaemia after ex-
Guillouzo C. Transient expression of c-fos and constant expression of c-myc in tended hepatectomy in dogs. Journal of Gastroenterology and Hepatology 1997;
freshly isolated and cultured normal adult rat hepatocytes. Oncogene Research 12:633–8.
1988;3:255–62. 41. Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplanta-
11. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43: tion reveals the stem-cell-like regenerative potential of adult mouse hepatocytes.
S45–S53. American Journal of Pathology 1997;151:1273–80.
12. Fausto N, Riehle KJ. Mechanisms of liver regeneration and their clinical impli- 42. Ozeki Y, Umemoto T, Tateyama K, Katagiri Y, Katayama M, Sugiyama A. Partial
cations. J Hepatobiliary Pancreat Surg 2005;12:181–9. portal arterialization for dearterialized liver after hepatectomy. British Journal of
13. Fausto N. Lessons from genetically engineered animal models. V. Knocking out Surgery 1997;84:1011.
genes to study liver regeneration: present and future. Am J Physiol 1999; 43. Palmes D, Spiegel H-U. Animal models of liver regeneration. Biomaterials
277(5):G917–21. 2004;25:1601–1611.
14. Fausto N. Liver regeneration. Journal of Hepatology 2000;32(suppl 1):19–31. 44. Pomfret EA, Pomposelli JJ, Gordon FD, et al. Liver regeneration and surgical
15. Fukuhara Y, Hirasawa A, Li XK, et al. Gene expression profile in the regenera- outcome in donors of right-lobe liver grafts. Transplantation 2003;76:5–10.
ting rat liver after partial hepatectomy. J Hepatol 2003;38:784–92. 45. Sakamoto T, Liu Z, Murase N, et al. Mitosis and apoptosis in the liver of inter-
16. Gaub J, Iversen J. Rat liver regeneration after 90% partial hepatectomy. Hepato- leukin-6-deficient mice after partial hepatectomy. Hepatology 1999;29:403–11.
logy 1984;4:902–4. 46. Sawada N. Hepatocytes from old rats retain responsiveness of c-myc expression
17. Golubovskaya VM, Presnell SC, Hooth MJ, Smith GJ, Kaufmann WK. Ex- to EGF in primary culture but do not enter S phase. Exp Cell Res 1989;181:
pression of telomerase in normal and malignant rat hepatic epithelia. Oncogene 584–8.
1997;15(10):1233–40. 47. Shao HY, Zhao LF, Xu CS. Expression patterns and action analysis of genes as-
18. Haber BA, Mohn KL, Diamond RH, Taub R. Induction patterns of 70 genes sociated with inflammatory responses during rat liver regeneration. World J
during nine days after hepatectomy define the temporal course of liver regenera- Gastroenterol 2007;13(3):369–77.
tion. J Clin Invest 1993;91:1319–26. 48. Sherlock S, Dooley J. Nemoci jater a žlučových cest. 1st Czech edition [Czech
19. Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration translation editor Petr Hůlek] Hradec Králové: Čermáková, 2004:703.
of the liver of the white rat following partial surgical removal. Arch. Pathol. 49. Starzl TE, Putnam CW, Groth CG, Corman JL, Taubman J. Alopecia, ascites,
1931;12:186–202. and incomplete regeneration after 85–90 per cent liver resection. American Jour-
20. Hockings PD, Roberts T, Campbell SP, et al. Longitudinal Magnetic Resonance nal of Surgery 1975;129:587–90.
Imaging Quantitation of Rat Liver Regeneration After Partial Hepatectomy. 50. Steer CJ. Liver regeneration. FASEB Journal 1995;9(14):1396–1400.
Toxicologic Pathology 2002;30(5):606–610. 51. Stocker E, Wullstein HK, Brau G. Capacity of regeneration in liver epithelia of
21. Hsieh LL, Peraino C, Weinstein IB. Expression of endogenous retrovirus-like se- juvenile, repeated partially hepatectomized rats. Autoradiographic studies after
quences and cellular oncogenes during phenobarbital treatment and regeneration continuous infusion of 3H-thymidine (author’s transl). Virchows Archiv 1973;
in rat liver. Cancer Res 1988;48:265–9. 14:93–103.
98
52. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK. Growth factor Rat Genome Database, update 2007 – easing the path from disease to data and
signal transduction immediately after two-thirds partial hepatectomy in the rat. back again. Nucleic Acids Research [online] 2007;35:D658–D662.
Cancer Res 1999;59:3954–60. 61. van Bakel H, Holstege FCP. A Tutorial for DNA Microarray Expression Profiling.
53. Strey CW, Markiewski M, Mastellos D, et al. The proinflammatory mediators In: Zuk D, ed. Evaluating Techniques in Biochemical Research. Cambridge, MA:
C3a and C5a are essential for liver regeneration. J Exp Med 2003;198:913–23. Cell Press, 2007:22–27.
54. Tarlá MR, Ramalho FS, Ramalho LNZ, et al. A molecular view of liver regene- 62. Wagenaar GT, Chamuleau RA, Pool CW, et al. Distribution and activity of glu-
ration. Acta Cir Bras 2006;21(suppl 1):58–62. [serial on the Internet]. Available tamine synthase and carbamoylphosphate synthase upon enlargement of the liver
from URL: http://www.scielo.br/acb lobule by repeated partial hepatectomies. J Hepatol 1993;17(3):397–407.
55. Tarlá MR, Ramalho FS, Ramalho LNZ, et al. Cellular aspects of liver regenera- 63. Wege H, Müller A, Müller L, Petri S, Petersen J, Hillert C. Regeneration in pig
tion. Acta Cir Bras 2006;21(suppl 1):63–66. [serial on the Internet]. Available livers by compensatory hyperplasia induces high levels of telomerase activity.
from URL: http://www.scielo.br/acb Comparative Hepatology 2007;6:6.
56. Taub R. Liver regeneration: from myth to mechanism. Nature Reviews Molecular 64. Xu CS, Chang CF, Yuan JY, et al. Expressed genes in regenerating rat liver after
Cell Biology 2004;5:836–47. partial hepatectomy. World J Gastroenterol 2005;11:2932–40.
57. The Gene Ontology Consortium. Gene ontology: tool for the unification of bio- 65. Xu CS, Zhang SB, Chen XG, Rahman S. Correlation analysis of liver tumor-
logy. Nature Genetics 2000;25(1):25–9. associated genes with liver regeneration. World J Gastroenterol 2007;13(24):
58. Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N. Sequential 3323–32.
protooncogene expression during rat liver regeneration. Cancer Res 1986;46: 66. Yokoya F, Okutsu T. Gene panel participating in liver regeneration. European
3111–7. Patent Office Bulletin 2004/01
59. Togo S, Makino H, Kobayashi T, et al. Mechanism of liver regeneration after par- 67. Yoshizumi T, Taketomi A, Uchiyama H, et al. Graft size, donor age, and patient
tial hepatectomy using mouse cDNA microarray. J Hepatol 2004;40:464–71. status are the indicators of early graft function after living donor liver transplan-
60. Twigger SN, Shimoyama M, Bromberg S, Kwitek AE, Jacob HJ. RGD Team. The tation. Liver Transpl 2008;14:1007–13.
Received: 03/06/2009.
Accepted in revised form: 20/09/2009.
Corresponding author:
David Rychtrmoc, MD, Charles University in Prague, Faculty of Medicine in Hradec Králové, Department of Physiology,
Šimkova 870, 500 38 Hradec Králové 1, Czech Republic; e-mail: rychtrmocd@lfhk.cuni.cz
99